If I were running Merck I would review ASCO updates to see if...

  1. 313 Posts.
    lightbulb Created with Sketch. 153
    If I were running Merck I would review ASCO updates to see if there are other complementary immune therapies for Keytruda Then make an offer for IMM before approval looks imminent
    It won’t get a lot cheaper
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
24.5¢
Change
0.000(0.00%)
Mkt cap ! $368.7M
Open High Low Value Volume
25.0¢ 25.3¢ 24.5¢ $245.6K 993.5K

Buyers (Bids)

No. Vol. Price($)
9 17029 24.5¢
 

Sellers (Offers)

Price($) Vol. No.
25.0¢ 649537 13
View Market Depth
Last trade - 11.10am 17/06/2025 (20 minute delay) ?
IMM (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.